{"name": "DxUpClose",
 "permalink": "dxupclose",
 "crunchbase_url": "http://www.crunchbase.com/company/dxupclose",
 "homepage_url": "http://www.dxupclose.com",
 "blog_url": "",
 "blog_feed_url": "http://www.dxupclose.com/home/news",
 "twitter_username": "DxUpClose",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "512-423-3865",
 "description": "",
 "created_at": "Thu Aug 16 03:49:58 UTC 2012",
 "updated_at": "Tue Apr 09 05:51:05 UTC 2013",
 "overview": "\u003Cp\u003EDxUpClose, Inc. is young company developing a point-of-care bacterial diagnostic that will perform an antibiotic sensitivity test in sixty minutes. \u003C/p\u003E\n\n\u003Cp\u003EThe product is designed to screen for specific bacteria, regardless if the sample has the targeted bacteria, it will count the bacteria that are there and perform antibiotic sensitivity tests - all within sixty minutes.  At the end of the test, the product will securely send a list of effective antibiotics to the Healthcare worker\u2019s email or smartphone, so results can be rapidly interpreted by a physician who can then either write a prescription or ePrescribe the appropriate antibiotic. This will reduce the delay in optimal patient care present today by one to three days. Their device is designed to weigh less than sixteen ounces, fit in a pocket, run on batteries and survive temperature extremes, making it easy to transport while still retaining its diagnostic reliability. \u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.prnewswire.com/news-releases/golden-seeds-invests-in-dxupclose-disruptive-technology-that-performs-an-antibiotic-sensitivity-test-at-the-patients-bedside-in-less-than-an-hour-166273696.html",
    "source_description": "Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Golden Seeds",
         "permalink": "golden-seeds",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0010/2188/102188v1-max-150x150.jpg"],
             [[215,
               63],
              "assets/images/resized/0010/2188/102188v1-max-250x250.jpg"],
             [[215,
               63],
              "assets/images/resized/0010/2188/102188v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "6170 Research Road, Suite #212",
    "address2": "",
    "zip_code": "75034",
    "city": "Frisco",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}